Richard B. Pollard
Technik-/Wissenschafts-/F&E-Leiter bei Genetic Immunity, Inc.
Profil
Richard B.
Pollard has been Chief Medical Officer of Genetic Immunity LLC since December, 2007.
He is a Professor of Internal Medicine an Microbiology and Chief of the Division of Infectious Diseases for Davis Medical School.
Dr. Pollard currently serves as the Principal Investigator of the Immunology Specialty Laboratory, Chairman of the ACTG Laboratory Evaluation Subcommittee, and Principal Investigator of the California Research Center for the Biology of HIV in Minorities.
He was Director of Research for US Navy.
Dr. Pollard was an Assistant Professor of Internal Medicine at the University of Texas at Galveston and appointed as a Professor of Internal Medicine, Pathology, and Microbiology in 1989.
He received his undergraduate degree from the University of Maryland in College Park and Baltimore.
Aktive Positionen von Richard B. Pollard
Unternehmen | Position | Beginn |
---|---|---|
Genetic Immunity, Inc.
Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2007 |
Ehemalige bekannte Positionen von Richard B. Pollard
Unternehmen | Position | Ende |
---|---|---|
The University of Texas at Austin | Corporate Officer/Principal | - |
Ausbildung von Richard B. Pollard
University of Maryland | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Genetic Immunity, Inc.
Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | Health Technology |